Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.20.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Income Statement [Abstract]        
Sales $ 60,228 $ 231,231 $ 474,546 $ 940,459
Cost of sales (80,995) (317,602) (571,621) (947,710)
Gross loss (20,767) (86,371) (97,075) (7,251)
Operating Expenses        
Selling and marketing 110,687 100,066 160,686 336,873
General and administrative 859,967 1,410,509 3,342,240 4,339,943
Depreciation and amortization 45,906 39,211 138,409 151,370
Gain from insurance settlement (30,240) (165,508) (30,240) (165,508)
Total operating expenses 986,320 1,384,278 3,611,095 4,662,678
Loss from Operations (1,007,087) (1,470,649) (3,708,170) (4,669,929)
Other Expense (Income)        
Interest expense, net 72,459 29,140 193,595 256,169
Gain on debt restructuring (130,421) (130,421)
Gains from foreign currency translation (14,826) (74,179) (35,316) (106,513)
Total other (income) expense (72,788) (45,039) 27,858 149,656
Net Loss (934,299) (1,425,610) (3,736,028) (4,819,585)
Net loss attributable to non-controlling interest 32,838 109,106 128,355 155,515
Series B preferred stock dividends (178,094) (181,746) (540,217) (539,311)
Net Loss Attributable to Common Stockholders $ (1,079,555) $ (1,498,250) $ (4,147,890) $ (5,203,381)
Net Loss per Common Share $ (0.02) $ (0.03) $ (0.07) $ (0.10)
Weighted Average Number of Common Shares Outstanding:        
Basic and Diluted 61,654,100 57,933,937 60,735,452 52,782,987